Mode
Text Size
Log in / Sign up

Cartilage Thickness Score shows higher values in future knee osteoarthritis cases in a cohort studyNew cartilage score predicts knee osteoarthritis onset and progression in study cohorts

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider the Cartilage Thickness Score as a potential associative marker for knee osteoarthritis progression, noting the observational study design.

This observational cohort study used data from the Osteoarthritis Initiative (OAI) and FNIH Biomarkers Consortium to evaluate the Cartilage Thickness Score (CTh-Score) as a marker for knee osteoarthritis milestones. The population included participants from the OAI, with specific cohorts for OA onset (307 matched case-control pairs), progression (164 cases and 369 controls), and knee replacement (KR) (81 cases and 324 controls). The CTh-Score was compared to conventional morphometric measures like radiographic minimum joint space width.

In the onset cohort, the CTh-Score was higher in future cases than controls at T-4Y (16.2 vs 12.6, p=0.007), T-2Y (23.5 vs 16.7, p<0.001), and T0 (39.8 vs 18.6, p<0.001). In the progression cohort at T-4Y, it was higher in cases (43.2 vs 33.0, p<0.001). In the KR cohort at T-4Y, it was higher in cases (55.4 vs 46.1, p=0.02). Adjusted models showed the CTh-Score was independently associated with all outcomes, with odds ratios per standard deviation increase ranging from 1.3 to 2.2.

Safety and tolerability were not reported. Key limitations include the observational design, which cannot establish causality, and the lack of reported absolute numbers for some effect sizes. The practice relevance supports the CTh-Score as a sensitive quantitative marker of cartilage damage severity across the OA continuum, but findings require validation in other settings.

This study examined cartilage thickness using a new scoring system called the Cartilage Thickness Score (CTh-Score) in participants from the Osteoarthritis Initiative. The researchers compared these scores against conventional measures like joint space width to see how well they predicted future knee problems. The group included participants from three specific cohorts: one looking at disease onset, one tracking progression, and one focused on those needing knee replacement. Follow-up assessments occurred at four years, two years, and the start of the study period.

The analysis found that the CTh-Score was consistently higher in individuals who later experienced incident radiographic osteoarthritis, combined pain and structural progression, or required a knee replacement. In the onset cohort, the score was significantly higher in future cases at all time points, with statistical significance ranging from p=0.007 to p<0.001. Similar patterns were seen in the progression and knee replacement cohorts, where the score remained higher in cases than controls at the four-year mark.

Further analysis using adjusted models showed that the CTh-Score was independently associated with all measured outcomes. The strength of this association varied, with odds ratios per standard deviation increase ranging from 1.3 to 2.2. The study did not report any adverse events, discontinuations, or safety concerns because it was an observational research project, not a clinical trial testing a new drug or procedure. Readers should take from this that the score appears to be a useful quantitative marker for cartilage damage severity across the osteoarthritis continuum, but it does not yet change current clinical practice.

What this means for you:
New cartilage score linked to future knee osteoarthritis in observational study data.

Study Details

Study typeCohort
EvidenceLevel 3
PublishedApr 2026
View Original Abstract ↓
Objective To evaluate the Cartilage Thickness Score (CTh-Score) as a quantitative measure of cartilage damage severity by assessing its association with three osteoarthritis (OA) milestones and comparing its performance with conventional morphometric measures (radiographic minimum joint space width (JSW) and regional average cartilage thickness). Methods Data were obtained from the Osteoarthritis Initiative (OAI) and the publicly available OAI CTh-Maps and CTh-Score dataset. Three matched case-control designs were used to represent major OA milestones: (i) incident radiographic OA onset, (ii) combined pain and structural progression, and (iii) knee replacement (KR) in the coming 2 years. Progression subjects were extracted from the FNIH Biomarkers Consortium cohort. Cases and controls were compared at 4 years (T-4Y), 2 years (T-2Y), and 0 years (T0) before the milestone. MRI-based CTh-Score and regional average cartilage thickness, as well as JSW, were analyzed cross-sectionally and longitudinally. Associations with case status were assessed using adjusted logistic regression models, and responsiveness was evaluated using longitudinal change and standardized response means. Results The onset cohort included 307 matched case-control pairs, the progression cohort 164 cases and 369 controls, and the KR cohort 81 cases and 324 controls. Across all three study designs, the CTh-Score significantly differentiated cases from controls at all timepoints. In the onset cohort, the CTh-Score was higher in future cases than controls at T-4Y (16.2 vs 12.6, p=0.007), T-2Y (23.5 vs 16.7, p<0.001), and T0 (39.8 vs 18.6, p<0.001), whereas JSW and regional thickness measures showed limited or later discrimination. Similar findings were observed for progression (43.2 vs 33.0 at T-4Y; p<0.001) and KR (55.4 vs 46.1 at T-4Y; p=0.02) cohorts. Longitudinally, CTh-Score changes differentiated cases from controls earlier and more consistently than JSW or regional average thickness, and its responsiveness was consistently the highest across OA milestones and time intervals. In adjusted models, the CTh-Score was independently associated with all outcomes at T-4Y and T-2Y, with odds ratios per standard deviation increase ranging from 1.3 to 2.2. Conclusion The CTh-Score captures high-resolution cartilage thickness patterns associated with OA onset, progression, and future knee replacement, outperforming conventional morphometric measures in early discrimination, responsiveness, and predictive association. These findings support CTh-Score as a sensitive quantitative marker of cartilage damage severity across the OA continuum.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.